Enterprise Tech Ecosystem Series: Almirall - 2025

Enterprise Tech Ecosystem Series: Almirall - 2025

Summary

Almirall is a global biopharmaceutical company specializing in dermatology. The company develops and commercializes solutions for the treatment of a variety of dermatological diseases such as acne, atopic dermatitis, actinic keratosis, vitiligo, onychomycosis, skin cancer, and psoriasis, among others. Some of the company’s key products are Wynora cream (for mild-to-moderate plaque psoriasis), Skilarence (for moderate-to-severe plaque psoriasis), and Actikerall (for hyperkeratotic actinic keratosis). The company also produces medicines for neurological, gastric, and cardiac diseases. The company sells a total of 143 products, of which 51 are for skin diseases.

The report provides information and insights into Almirall's tech activities, including -

• Insights of its digital transformation strategies and innovation programs.
• Overview of technology initiatives covering partnerships and product launches.
• Insights on each technology initiative including technology theme, objective, and benefits.
• Details of estimated ICT budgets and major ICT contracts.

• The report provides insights into the company’s tech activities, including its digital transformation strategies, its innovation programs, and its technology initiatives.

• Gain insights into Almirall's tech operations.
• Gain insights into its tech strategies and innovation initiatives.
• Gain insights into its technology themes under focus.
• Gain insights into various product launches and partnerships.